Skip to content
BOLUS

Signal from the log

Precision Neuroscience

250 M$ · Series D and later · United States · Medtech

Precision Neuroscience développe Layer 7, un film d'électrodes posé à la surface du cortex sans percer le tissu, pour que des personnes paralysées pilotent un ordinateur par la pensée. La FDA a autorisé en 2025 une version à 1 024 électrodes, pour moins de trente jours ; l'implant permanent reste en développement.

Article

Announced on , logged by the watch of 24 September 2026.

Operation
Funding round
Announced amount
250 M$
Stage
Series D and later
Country
United States
Sector
Medtech

What the log says

Editorial note, in French

Sujet traité. L'article donne les sources et la position de Bolus.

The investors

Led by Pershing Square , Ackman Oxman Institute , with Duquesne Family Office , B Capital , ARK Invest , Invus , Mubadala Capital , Mirae Asset Capital , Korea Investment Partners , Hitachi Ventures , JSL Health Capital

Read the article on this operation (in French)

Provenance
Source divenewsletter,fortune,globenewswire
Logged on 24 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Article The operation led to an article, with its sources checked one by one.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).